title: Capsaicin-induced bladder hyperactivity in normal conscious rats.
abstract: Capsaicin, instilled intravesically in normal, unanesthetized rats induced a concentration-dependent bladder hyperactivity, which could be abolished by hexamethonium, given intra-arterially near the bladder, or by morphine administered intrathecally. The effect was reversible and could be repeated. The NK-2 receptor selective antagonist SR 48,968 and the nonselective NK receptor antagonist spantide, given intra-arterially near the bladder, which by themselves, in the concentrations used, did not affect cystometric parameters, both counteracted the capsaicin-induced hyperactivity, whereas the NK-1 receptor selective antagonist RP 67,580 failed to do so. Blockade of tachykinin receptors in the urinary bladder does not seem to produce changes of the micturition reflex associated with bladder filling in the conscious rat. However, tachykinins released from capsaicin-sensitive nerves by various stimuli may, through stimulation of NK-2 receptors, lower the threshold for initiation of the micturition reflex. In the rat, intravesical capsaicin may be a suitable model for studies of afferent activity caused by stimuli releasing peptides from sensory nerves in the bladder, thereby provoking bladder hyperactivity.
authors.affiliation: Department of Urology, Lund University Hospital, Sweden.
authors.forename: O
authors.initials: O
authors.lastname: Ishizuka
authors.forename: Y
authors.initials: Y
authors.lastname: Igawa
authors.forename: A
authors.initials: A
authors.lastname: Mattiasson
authors.forename: K E
authors.initials: KE
authors.lastname: Andersson
mesh_terms: D000283:Administration, Intravesical; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D002211:Capsaicin / Q000494:pharmacology*; D003243:Consciousness; D004305:Dose-Response Relationship, Drug; D005260:Female; D018738:Hexamethonium; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D054833:Isoindoles; D009020:Morphine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018039:Receptors, Tachykinin / Q000037:antagonists & inhibitors; D013373:Substance P / Q000031:analogs & derivatives; D001743:Urinary Bladder / Q000187:drug effects* / Q000294:innervation*
chemical_list: D001549:Benzamides; D006584:Hexamethonium Compounds; D007211:Indoles; D054833:Isoindoles; D010880:Piperidines; D018039:Receptors, Tachykinin; C071693:7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one; D013373:Substance P; D018738:Hexamethonium; C073839:SR 48968; D009020:Morphine; C042867:spantide; D002211:Capsaicin